HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michele Musci Matthias Bauer Roland Hetzer Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zurbrügg, H. R. Articles by Hetzer, R. Search for Related Content PubMed PubMed Citation Articles by Zurbrügg, H. R. Articles by Hetzer, R.

Ann Thorac Surg 2000;70:1536-1540
© 2000 The Society of Thoracic Surgeons

---

Original articles: cardiovascular

The biocompound method in coronary artery bypass operations: surgical technique and 3-year patency

^a Deutsches Herzzentrum Berlin, Berlin, Germany

Address reprint requests to Dr Zurbrügg, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
e-mail: zurbruegg{at}dhzb.de

Background. Complete arterial revascularization may be unsafe in patients with a high operative risk. In patients with varicose ectatic veins, the biocompound technique, which uses unsuitable autologous veins, enables the surgeon to influence the bypass graft wall stress levels and diameter. This report summarizes the 3-year patency of 53 patients, the survival rate of 200 patients, and operative technical considerations.

Methods. Biocompound grafts were used for aortocoronary bypass in 200 patients who were considered inappropriate subjects for complete arterial revascularization and who had unsuitable saphenous veins.

Results. The mortality rate (30 days) of 200 patients was 3.5%. The 3-year survival rate was 88.5%. The patency rate of the left internal thoracic artery (LITA) after 3 years was 97.3%, of the native vein was 68.7%, and of the biocompound graft was 68.3%. The LITA showed a superior patency rate (p = < 0.05).

Conclusions. The LITA is the first choice in coronary bypass operation. The biocompound technique is a reliable method to achieve complete revascularization in patients with a lack of suitable saphenous veins.

This article has been cited by other articles:

				P. Human, T. Franz, J. Scherman, L. Moodley, and P. Zilla Dimensional analysis of human saphenous vein grafts: Implications for external mesh support. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1101 - 1108. [Abstract] [Full Text] [PDF]

				K. Laflamme, C. J. Roberge, G. Grenier, M. Remy-Zolghadri, S. Pouliot, K. Baker, R. Labbe, P. D'Orleans-Juste, F. A. Auger, and L. Germain Adventitia contribution in vascular tone: insights from adventitia-derived cells in a tissue-engineered human blood vessel FASEB J, June 1, 2006; 20(8): 1245 - 1247. [Abstract] [Full Text] [PDF]

				C. Recek Saphenofemoral Junction Ligation Supplemented by Postoperative Sclerotherapy: A Review of Long-Term Clinical and Hemodynamic Results Vascular and Endovascular Surgery, November 1, 2004; 38(6): 533 - 540. [Abstract] [PDF]

				W. Stooker, H.W.M. Niessen, W.R. Wildevuur, V.W.M. van Hinsbergh, J. Fritz, E.K. Jansen, Ch.R.H. Wildevuur, and L. Eijsman Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 212 - 217. [Abstract] [Full Text] [PDF]